J. Reginster

Orthopedics and Sports Medicine · 2000–2020

A researcher in the Science corpus: 19 papers; trusts 11 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Orthopedics and Sports Medicine — 157 citations into it; #425 of 427 by trust here, #21 by citations
• Oncology — 79 citations into it
• Surgery — 75 citations into it
• Molecular Biology — 38 citations into it
• Pediatrics, Perinatology and Child Health — 8 citations into it

Whom J. Reginster trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Kanis
2. O. Johnell
3. Steve Cummings
4. A. Odén
5. C. Laet
6. L. Melton
7. J. Cauley

Who trusts J. Reginster overall

1. J. Kanis
2. Chris Cooper
3. T. Sözen

Papers from J. Reginster's perspective

Ordered by how strongly the researchers J. Reginster trusts endorse each paper. Same corpus, a different order for every researcher.

1. The Use of Biochemical Markers of Bone Turnover in Osteoporosis (Osteoporosis International)
2. Diagnosis of osteoporosis and assessment of fracture risk. (The Lancet)
3. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women (Osteoporosis International)
4. Risk of Mortality Following Clinical Fractures (Osteoporosis International)
5. Use of Oral Corticosteroids and Risk of Fractures (Journal of Bone and Mineral Research)
6. International Variations in Hip Fracture Probabilities: Implications for Risk Assessment (Journal of Bone and Mineral Research)
7. Long-Term Risk of Osteoporotic Fracture in Malmö (Osteoporosis International)
8. The Burden of Osteoporotic Fractures: A Method for Setting Intervention Thresholds (Osteoporosis International)
9. The effect of risedronate on the risk of hip fracture in elderly women. (New England Journal of Medicine)
10. Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate (Journal of Bone and Mineral Research)

Their papers

• European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008) — 1,822 citations
• Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis (2000) — 1,657 citations
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008) — 996 citations
• Fragility fractures in Europe: burden, management and opportunities (2020) — 665 citations
• Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management (2019) — 833 citations
• Consequences of maternal postpartum depression: A systematic review of maternal and infant outcomes (2019) — 1,343 citations
• Pitfalls in the measurement of muscle mass: a need for a reference standard (2018) — 664 citations
• European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2018) — 928 citations
• Evidence for the Domains Supporting the Construct of Intrinsic Capacity (2018) — 618 citations
• Sarcopenia: revised European consensus on definition and diagnosis (2018) — 11,542 citations
• Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis (2017) — 1,108 citations
• 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. (2017) — 792 citations
• Sarcopenia in daily practice: assessment and management (2016) — 743 citations
• The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. (2014) — 620 citations
• Osteoporosis: a still increasing prevalence. (2005) — 1,023 citations
• Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. (2005) — 1,102 citations
• Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. (2004) — 1,846 citations
• Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. (2001) — 4,531 citations
• Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. (2001) — 1,607 citations